ArticleThe British journal of dermatology2022

Clinical response to rituximab and improvement in quality of life in patients with bullous pemphigoid and mucous membrane pemphigoid.

H Rashid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.